$28.38 0.08 (+0.28%)
11/9/2009 11:11 AM

Medivation, Inc. (MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Current Price $28.38 Mkt Cap $951M
Open $28.45 P/E Ratio 0.00
Prev. Close $28.30 Div. (Yield) N/A (N/A)
Daily Range $28.20 - $28.49 Volume 164,651
52-Wk Range $11.27 - $28.40 Avg. Daily Vol. 426,000

MDVN News and Commentary

Related News and Articles

Caps

How do you think MDVN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

85 Outperform
27 Underperform
 

All-Star Members

23 Outperform
8 Underperform
 

Wall Street

7 Outperform
1 Underperform
 

Top MDVN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

henncoop (98.64)
Submitted June 14, 2007

shows some great promise with new alzhiemer's drug ...other drugs in the pipeline as well

rfreyermuth (< 20)
Submitted December 16, 2006

great management and great model

MDVN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MDVN.

Recs

0
Member Avatar StockSouter (26.82) Submitted: 11/3/2009 2:59:08 PM : Outperform Start Price: $26.63 MDVN Score: +2.43

Stock is priced on MDV 3100 future revenue alone which gets you the dimebon chance for success for free

Recs

0
Member Avatar quinpeung (32.97) Submitted: 5/9/2009 8:56:40 AM : Underperform Start Price: $19.06 MDVN Score: -26.67

Dimebon may be the best candidate to treat Alzheimer's disease, which is not saying much. Nevertheless, current economic climate makes this red thumb a solid CAPS play.

Recs

0
Member Avatar FSaucy (99.85) Submitted: 3/4/2009 10:47:59 AM : Underperform Start Price: $14.70 MDVN Score: -38.21

Zero revenue + $400 M market cap = Lots of high hopes

Leaderboard

Find the members with the highest scoring picks in MDVN.

Score Leader

TrackRodmanRen

TrackRodmanRen (< 20) Score: +185.55

The Score Leader is the member with the highest score across all their picks in MDVN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
hopphys 69.73 11/20/2006 Outperform 5Y $13.18 +115.52% -17.79% +133.31
canoesail1 < 20 10/23/2006 Outperform 3M $13.15 +116.01% -15.58% +131.59
cysto 91.00 1/4/2008 Outperform NS $13.52 +110.10% -19.94% +130.03
hayrettin 77.09 7/8/2008 Outperform NS $13.14 +116.25% -11.39% +127.65
steveandteresa 52.13 10/11/2006 Outperform 5Y $13.35 +112.77% -14.50% +127.27
Dixie5346 59.42 10/11/2006 Outperform 1Y $13.35 +112.77% -14.50% +127.27
Hosannah 37.17 10/16/2006 Outperform 1Y $13.43 +111.50% -15.55% +127.05
MaximusPlexus < 20 11/29/2007 Outperform 1Y $14.33 +98.22% -22.59% +120.81
bizunit 24.31 5/21/2008 Outperform 3Y $14.19 +100.18% -20.57% +120.74
1chuck 28.71 10/11/2006 Outperform 3Y $13.75 +106.51% -14.15% +120.66

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRothCapital 75.98 11/5/2009 Outperform NS $27.08 +4.89% +2.80% +2.09
TrackJPMorgan 79.08 10/30/2009 Outperform NS $25.59 +11.00% +3.26% +7.74
TrackHapoalim 49.84 3/5/2009 Outperform NS $15.57 +82.43% +57.77% +24.67
TrackLeerinkSwan 84.10 9/4/2008 Outperform NS $29.67 -4.26% -11.63% +7.37
TrackRodmanRen < 20 7/8/2008 Outperform NS $12.45 +128.15% -10.33% +138.48
TrackStanfordRes 80.32 1/29/2008 Outperform NS $17.85 +59.13% -16.83% +75.96
TrackRothCapital 75.98 1/17/2008 Outperform NS $15.77 +26.82% -43.73% +70.56 2/26/2009 @ $20.00
TrackBreanMurray 89.57 11/7/2007 Underperform NS $20.77 +36.76% -24.43% -61.19
TrackPacificGrow 88.33 10/31/2007 Outperform NS $21.49 +32.18% -26.07% +58.25
TrackRodmanRen < 20 10/4/2006 Outperform NS $10.19 +52.99% +5.92% +47.07 1/4/2007 @ $15.59

Featured Broker Partners